Behçet's disease: Uveitis-therapy with interferon α2a - Prospective clinical study in 33 patients;Morbus behçet: Uveitis-therapie mit interferon α2a - Prospektive klinische (pilot-)studie an 33 patienten

Klinische Monatsblatter fur Augenheilkunde

Volumn 218, Issue 12, 2001, Pages 768-773

  Stübiger, Nicole ^a   Kötter, Ina ^a   Deuter, Christoph ^a   Zierhut, Manfred ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Beh et's disease; Interferon 2a; Posterior uveitis; Retinal vasculitis

Indexed keywords

ALPHA2 INTERFERON; AZATHIOPRINE; CYCLOSPORIN A;

ADULT; ARTHRALGIA; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; DEPRESSION; DRUG EFFICACY; FEMALE; FEVER; FIBROMYALGIA; HAIR LOSS; HEADACHE; HUMAN; MALE; PRURITUS; REMISSION; RETINA VASCULITIS; SCORING SYSTEM; SYSTEMIC VASCULITIS; UVEITIS; VISUAL ACUITY;

EID: 0035690952     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-19687     Document Type: Article

References (38)

1. Visualisation of the vasculitis of Behçet disease
2. The neglected role of type I interferon in the T-cell response: Implications for it's clinical use
3. Behçet's disease: Activated T-lymphozytes in retinal perivasculitis
4. Prognostic oculaire de la maledie de Behçet
5. Interferon alfa-2b, colchizine, and benzathine penicillin in Behçet's disease
6. Beneficial effects of interferon-α2b in Behçet's disease
7. Detection of RNA complementary to herpes simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral aphthous ulcers
8. Immunopathological aspects of Behçet's disease
9. Interferon-α2b for refractory Behçet's disease
10. Interferontherapie und autoimmunität
11. Interferon-associated retinopathy
12. Cytotoxic T cells against herpes simplex virus in Behçet's Disease
13. Systemic interferon α2b treatment in Behçet's syndrome
14. Treatment ot Behçet's disease
15. Occurence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C
16. Criteria for dia-gnosis of Behçet's disease
17. Retinal complications during interferon therapy for chronic hepatitis C
18. Parovirus B19 infection in Behçet's disease
19. Erosive arthritis and posterior uveitis in Behçet's disease. Treatment with interferon α and γ
20. Therapy of Behçet's disease
21. Treatment of ocular symptoms of Behçet's disease with interferon α2a: A pilot study
22. T cell immunomodulation in Behçet's disease and consideration of microbial etiology involving herpes simplex virus, heat shock proteins and streptococcal antigens
23. Double masked trial of cyclosporin versus colchizine and long-term open study of cyclosporin in Behçet's disease
24. Interferon-alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus
25. Induction of Behçet's disease symptoms after dental treatment and streptococcus antigen skin test
26. Possible association between Behçet's syndrome and chronic hepatitis virus infection
27. Effectiveness of cyclosporin therapy for Behçet's disease
28. Anterior ischemic optic neuropathy secondary to interferon alfa
29. Behçet's disease: Classification and assessment of Rheumatic diseases: Part I
30. Ophthalmic features of Behçet's disease
31. The association between HLA B5 and ocular involvement of Behçet's disease in southern Turkey
32. A controlled trial of azathioprine in Behçet's syndrome
33. CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease
34. Behçet's disease, epidemiology and eye manifestations in German and Mediterranean patients
35. HLA-Muster bei morbus Adamantiades-Behçet in Deutschland
36. Morbus Adamantiades-Behçet. Therapeutischer einsatz von systemischem rekombinantem Interferon α2a